When LLSC was founded in 1955, a diagnosis of leukemia, lymphoma, Hodgkin's disease or myeloma was almost always fatal. Today, thanks to innovative research funded in part by LLSC, survival rates for some blood cancers have doubled and even quadrupled.
Learn more by participating over the telephone and online in upcoming webcasts.
Visit this page to access virtual lectures, audio replays and program slides from past programs.
Immunotherapy: is using the immune system to tackle cancer a reality?
The newest form of cancer treatment is based on the concept that immune cells or antibodies that can recognize and kill cancer cells in the laboratory can then be given to patients to treat cancer. Several types of immunotherapy are either approved for use or are under study in clinical trials to determine their effectiveness in treating various types of cancer, including blood cancers.
The topics covered include:
- Overview of immunotherapy
- How immunotherapy works
- Which patients are eligible for immunotherapy
- Getting the latest treatments to patients
Dr. Denis Claude Roy
English webcast: February 16, from 2:30 p.m. to 3:45 p.m. ET
The educational webcast is available in French or English, will be approximately 1 hour in length followed by question period and advance registration is required.
The French webcast is on February 9, from 2:30 p.m. to 3:45 p.m. ET, and to register, click here.
This Webcast is made possible thanks to the support of